Table 3.
Laboratory parameters of group 2 patients with and without CAN.
| Laboratory features | Without CAN | CAN | p |
|---|---|---|---|
| n = 12 | n = 36 | ||
| 25 (OH)D (ng/mL) | 32 ± 6.3 | 27.8 ± 8.3 | 0.04 |
| Glucose (mg/dL) | 147.7 ± 33.9 | 166.3 ± 67.7 | 0.22 |
| HbA1c (%) | 8.3 ± 1.4 | 8.2 ± 1.2 | 0.84 |
| Creatinine (mg/dL) | 1.5 ± 0.6 | 1.4 ± 0.3 | 0.50 |
| Clearance (CKD-EPI) mL/min/1,73m²) | 47.8 ± 16.5 | 52.4 ± 12.7 | 0.33 |
| Total cholesterol (mg/dL) | 182.4 ± 46.0 | 188.8 ± 50.7 | 0.70 |
| HDL (mg/dL) | 41 (34–43) | 37 (31 – 45) | 0.60 |
| LDL (mg/dL) | 100.8 ± 52.2 | 100.8 ± 41.4 | 1.00 |
| Triglycerides (mg/dL) | 212 ± 117.4 | 239.7 ± 166.5 | 0.60 |
| Mean albuminuria (mg/g) | 652.1 (170.8 - 1390.2) | 455 (179.4-733.9) | 0.23 |
| Mean albuminura (log10) | 2.8 (2.2 - 3.1) | 2.7 (2.3 - 2.9) | 0.23 |
25(OH)D, 25-hydroxyvitamin D; HbA1c, Glycated hemoglobin; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; HDL, High-density lipoprotein; LDL, Low-density lipoprotein.